A
Amiri-Kordestani, Laleh
H指数:0
被引数:118
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
CLINICAL CANCER RESEARCH
IF10.2
FDA批准摘要: Enfortumab Vedotin联合Pembrolizumab治疗局部晚期或转移性尿路上皮癌
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
FDA批准摘要: Lu 177 Vipivotide四氧唑烷用于转移性去势抵抗性前列腺癌患者
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2
CLINICAL CANCER RESEARCH
IF10.2

